-
Product Insights
NTPC Rajasthan NSM DCR Solar PV Park – 8
NTPC Rajasthan NSM DCR Solar PV Park - 8 is a solar PV project located in Rajasthan, India. The project came online in 2017. Empower your strategies with our NTPC Rajasthan NSM DCR Solar PV Park - 8 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
NTPC Rajasthan NSM DCR Solar PV Park – 9
NTPC Rajasthan NSM DCR Solar PV Park - 9 is a solar PV project located in Rajasthan, India. The project is owned and developed by Maharashtra Seamless Ltd. The project came online in 2017. Empower your strategies with our NTPC Rajasthan NSM DCR Solar PV Park - 9 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewNet Present Value Model: Eli Lilly and Co’s LY-3819469
Empower your strategies with our Net Present Value Model: Eli Lilly and Co's LY-3819469 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. Eli Lilly and Co's LY-3819469 Drug Details: LY-3819469 (DCR-CM2) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lepodisiran Sodium in Atherosclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lepodisiran Sodium in Atherosclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lepodisiran Sodium in Atherosclerosis Drug Details: Lepodisiran sodium (LY-3819469, DCR-CM2) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3819469 in Atherosclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3819469 in Atherosclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3819469 in Atherosclerosis Drug Details: LY-3819469 (DCR-CM2) is under development for the...
-
Product Insights
DCR dev/ Havery Road / Robert Weiler – Avery Road Mixed-Use Development – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our DCR dev/ Havery Road / Robert Weiler - Avery Road Mixed-Use Development - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Company Profile
Dicerna Pharmaceuticals Inc – Company Profile
Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platform GalXCTM is an advanced next-generation RNAi-based therapies that is designed to silence disease-driving genes in the liver. Dicerna’s GalXC-based therapies are processed by the Dicer enzyme, which is the natural initiation point for RNAi within the human cell. The...
Add to Basket -
Product Insights
Net Present Value Model: Belcesiran
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Belcesiran Drug Details Belcesiran (DCR-A1AT) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LY-3819469
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry LY-3819469 Drug Details LY-3819469 (DCR-CM2) is under development for the treatment of diabetes and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RG-6346
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RG-6346 Drug Details RG-6346 (DCR-HBV) is under development for the treatment of chronic hepatitis...